Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 3 3Phase 1 2Phase 4 1Phase 2/3 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Neoplasms 2012Carcinoma, Non-Small-Cell Lung 1228Breast Neoplasms 1215Leukemia, Myeloid, Acute 967Neoplasm Metastasis 902Melanoma 778Colorectal Neoplasms 752Multiple Myeloma 725Lymphoma 725Ovarian Neoplasms 675Pancreatic Neoplasms 665Lymphoma, Non-Hodgkin 659Prostatic Neoplasms 657Recurrence 637Precursor Cell Lymphoblastic Leukemia-Lymphoma 585Lung Neoplasms 560Leukemia, Lymphocytic, Chronic, B-Cell 555Glioblastoma 527Leukemia 486Lymphoma, Large B-Cell, Diffuse 440Lymphoma, Follicular 419Brain Neoplasms 415Squamous Cell Carcinoma of Head and Neck 389Stomach Neoplasms 387Carcinoma, Renal Cell 385Myelodysplastic Syndromes 382Carcinoma, Hepatocellular 368Advanced Solid Tumors 357Lymphoma, Mantle-Cell 345Glioma 343

Interventions

Topotecan 1Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Interventional × Meningitis × Clear all
NCT00074607 2012-11-12

Intrathecal Gemcitabine to Treat Neoplastic Meningitis, IT Gemcitabine

Baylor College of Medicine

Phase 1 Terminated
10 enrolled
CNS

Meningitis, Neoplasms, Meningeal Carcinomatosis

NCT00674674 2012-05-15

PBTC-019

Baylor College of Medicine

Phase 1 Completed
22 enrolled
CNS

Meningitis, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡